Save The Date: November 1-2, 2017
10 on the Park, New York City

Speakers

2017 Speakers and Panelists

  • Linda Amper, PhD, President, Linda E Amper LLC
  • Anjan Aralihalli, MBA, Venture Partner, CTI Life Sciences
  • Sandipan Bagchi, Director, New Business Development, Fortress Biotech
  • Hannah M. Bayer, PhD, Chief Scientist, The HUMAN Project
  • Jodi B. Black, PhD, Deputy Director, National Institutes of Health – Office of Extramural Research
  • Jeffrey M. Bockman, PhD, Senior Vice President, Oncology Practice Head, Defined Health
  • Scott P. Bruder, MD, PhD, Founder and CEO, Bruder Consulting and Venture Group
  • Faith L. Charles, Partner , Corporate Transactions and Securities Group and Chair, Life Sciences, Thompson Hine
  • Hans Christinger, MS, MBA, VP, Business Development & Alliance Management, Ovid Therapeutics
  • Ellen B. Corenswet, Senior Counsel, Covington & Burling LLP
  • Vlad Coric, MD, Chief Executive Officer and Director, Biohaven Pharmaceuticals
  • Sara Jane Demy, Founder & CEO, Demy-Colton
  • Catarina R. Dolsten, Change Management Expert, Consultant and Executive Coach
  • Peter Donnelly, MS, MBA, Managing Director, Accelerate NY Seed Fund
  • Deborah Dunsire, MD, CEO and President, Xtuit Pharmaceuticals
  • Joan Fallon, DC, Founder and CEO, Curemark
  • Andrew Farquharson, Managing Director and Co-Founder, InCube Ventures
  • James E. Flynn, Managing Partner, Deerfield
  • Jonathan Garen, Chief Business Officer, uniQure
  • Kaushik Ghosal, PhD, Director of Business Development, BioMotiv
  • Harry Glorikian, MBA, General Partner, New Ventures Funds
  • Colin Goddard, PhD, Chief Executive Officer, BlinkBio
  • Stephen Goodman, JD, Co-Founder, Mid Atlantic Bio Angels; Partner, Pryor Cashman LLP
  • Sherry Grisewood, CFA, Senior Investment Officer, FoxHill Asset Management
  • Sonia Gulati, PhD, Assistant Director, New York Ventures
  • Joseph V. Gulfo, MD, MBA, CEO, Breakthrough Medical Innovations, LLC
  • Kenton C. Hasson, PhD, Senior Manager, Business Development & Innovation, Cannon BioMedical
  • Timothy Hemesath, PhD, Director, External R&D Innovation, Site Lead New York Centers for Therapeutic Innovation, Pfizer In
  • Dana C. Hilt, MD, Chief Medical Officer, Lysosomal Therapeutics Inc.
  • Olivier Jarry, Senior Advisor, Columbia Capital
  • Ginger S. Johnson, PhD, CEO, Defined Health
  • Pavel Khrimian, Associate Director, Partnering and Strategy, MedImmune 
  • Kevin Koch, Venture Partner, Orbimed
  • Wayne C. Koff, PhD, President and CEO, Human Vaccines Project
  • Brian Korb, Managing Director, The Trout Group LLC
  • Kristen Kosofsky, Senior Managing Director, Hercules Technology Capital
  • Steven Kreit, CPA, Partner in Charge – NY Technology and Life Science Practice, EisnerAmper LLP
  • Bart Kus, PhD, Associate Director, Partnering and Strategy (Business Development) MedImmune
  • Elisabeth Leiderman, MD, Vice President, Corporate Development Fortress Biotech
  • Keith Lenden, Venture Partner, ARCH Venture Partners
  • Douglas W. Losordo, MD, FACC, FAHA, Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer, Caladrius Biosciences
  • Sanford J. Madigan, PhD, Senior Vice President, COI Pharmaceuticals, Inc.
  • Gene Mancino, Partner, Mancino Burfield Edgerton
  • John M. McGill, PhD, Senior Director, LRL Science and Technology Partnerships, Lilly Research Laboratories, Eli Lilly and Company
  • Christopher Mortko, PhD, Executive Director, Oncology Search & Evaluation Lead, Merck
  • John Mumm, PhD, Director of Immunoncology R&D, MedImmune
  • Sanjeev Munshi, Ph.D, MBA, Director, Business Development and Licensing, Merck
  • Ilona Nemeth, Managing Parnter, Rumi Scientific
  • C. David Nicholson, PhD, EVP & Chief R&D Officer, Allergan
  • Bernard Peperstraete, MD, President and CEO, Acuamark Diagnostics, Inc.
  • Sergei Petukhov, PhD, Partner, Enso Ventures
  • Suresh M. Pitram, PhD, Advisor, External Innovation, Elanco Animal Health, a Division of Eli Lilly and Company
  • William S. Podd President & Executive Director Landmark Angels and Landmark Family Office
  • Alexander S. Preker, President & CEO, Health Investment & Financing Corporation
  • Dennis J. Purcell, Founder and Senior Advisor, Aisling Capital LLC
  • Kiran Reddy, MD, MBA, Venture Partner, Clarus Ventures
  • Michael C Rice, MS, MBA, Principal, Defined Health
  • John F. Resek, PhD, Partner, Carter, DeLuca, Farrell & Schmidt, LLP
  • Alan S. Roemer, MBA, MPH, SVP, Corporate Development, Roivant Sciences, Inc.
  • Issi Rozen, Chief Business Officer, Broad Institute of Harvard and MIT
  • Charles S. Ryan, JD, PhD, President and Chief Executive Officer, Orthobond Corporation
  • Ed Saltzman, Executive Chairman, Defined Health
  • Joel S. Sandler, PhD, Associate Principal, Defined Health
  • Joseph Scaduto, MS, MBA, Founder & CEO, Traverse Biosciences
  • Barbara S. Schilberg, Managing Director and Chief Executive Officer, BioAdvance
  • Ben Scruggs, PhD, Analyst, Hatteras Venture Partners
  • Nimish Shah, MBA, Vice President, Venrock
  • Bavani Shankar, MBA, Senior Director, Business Development, Scientific Partnering & Alliances, AstraZeneca
  • Todd Sherer, PhD, Chief Executive Officer, Michael J. Fox Foundation for Parkinson’s Research
  • Robert A. Silverman, Head, Externalized Drug Discovery Partnering, Roche
  • Pinki Singh, Manager, Oncology Innovation, Eli Lilly and Company
  • Kumar Srinivasan PhD, MBA, VP of Scientific Partnering and Alliance, AstraZeneca
  • Barry Ticho, MD, PhD, Chief Medical Officer, Stoke Therapeutics, Inc.
  • Robert Urban, PhD, Head, Johnson & Johnson Innovation
  • Santhosh Vadivelu, PhD, President and Chief Executive Officer, EpiDestiny
  • Samuel A. Waxman, Partner, Corporate Development, Paul Hastings
  • Bob Williams, President, IVMatters
  • Anton Xavier, MS, MBA, NY/NYC Biotech Scout, Targeted Therapeutics Discovery, Pfizer WRD
  • Peter Young, Executive-in-Residence, Pappas Ventures
  • Tingting Zhang-Kharas, PhD, Advisor – Oncology External Innovation, Eli Lilly and Company
  • Alex Zisson, Managing Director, H.I.G. Capital

Click here to view a list of our 2016 speakers